Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Immunyx Logo
Immunyx Growth Score
81
CB Rank
759042
Heat Score
35
Immunyx is a drug development company that produces and markets complete therapeutic products for neutrophils and immune cells.
Founded
obfuscation
Private Jerusalem, Yerushalayim, Israel1-10 www.immunyx.com/
Health Care
Health Diagnostics
Medical
Overview

Immunyx
Growth Score
81
Heat Score
35

Growth Score81
-5 pts
in past quarter
Heat Score 35
-12 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Immunyx

CB Rank
759042
Immunyx is a drug development company that produces and markets complete therapeutic products for neutrophils and immune cells.
Founded
obfuscation
Private Jerusalem, Yerushalayim, Israel1-10 www.immunyx.com/
Health Care
Health Diagnostics
Medical

Details

Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Neutrophil Modulating Drug Candidates
Drug candidates designed to modulate the toxic activity of neutrophils in chronic diseases such as COPD, cancer, colitis, and arthritis.
Targeted Nanoparticle Drug Delivery Platform
A platform that packages drugs into targeted nanoparticles to improve delivery accuracy and reduce systemic toxicity in neutrophil-related therapies.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Contacts 1
News

News and Press

News•Jan 23, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

255
275%
 in past month

IT Spend

$8.8MThis year, Immunyx is projected to spend $8.8M on IT, according to Aberdeen.

Active Website Tech Count

27Immunyx is actively using 27 technologies for its website, according to BuiltWith. These include SPF, Google Font API, and  Apple Mobile Web Clips Icon.
Sub-Organizations
Frequently Asked Questions

Where is Immunyx's headquarters? Immunyx is located in Jerusalem, Yerushalayim, Israel.Who are Immunyx's competitors? Alternatives and possible competitors to Immunyx may include Sanofi, Nuvig Therapeutics, and  Dren Bio.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(8ea058e 1)
|